PR NewswirePress Release: Jazz Pharmaceuticals plc; Wake Up Narcolepsy – Thu, Mar 22, 2012 9:00 AM EDT
WASHINGTON and DUBLIN, March 22, 2012 /PRNewswire/ -- Wake Up Narcolepsy and Jazz Pharmaceuticals plc (Nasdaq: JAZZ - News) have teamed up with professional golfer, Nicole Jeray to launch the 2012 Swinging for Sleep online fundraising campaign. The campaign raises funds to support narcolepsy awareness, research and patient support programs through nonprofit organizations dedicated to the narcolepsy community.
To view the multimedia assets associated with this release, please click http://www.prnewswire.com/news-releases/wake-up-narcolepsy-and-jazz-pharmaceuticals-announce-swinging-for-sleep-to-raise-funds-for-narcolepsy-awareness-143789786.html
"Narcolepsy is a neurological sleep disorder that often takes years to properly diagnose. Having battled this challenging condition for years, I understand first-hand the impact of the disease and how important it is to help others navigate living with it," said Nicole Jeray. "Swinging for Sleep is a great way for the narcolepsy community to come together to support the needs of patients and bring attention to this underdiagnosed condition."
Through Swinging for Sleep, Jazz Pharmaceuticals will donate $250 or $1000 for each "birdie" or "eagle" (low-swing scores on a single golf hole) respectively that Nicole Jeray scores during the 2012 LPGA Symetra Tour. Individuals are also encouraged to participate in the program by making a donation of their choice on Nicole's web site at www.nicolejeray.com. WUN will use proceeds raised by Swinging for Sleep to support awareness and research initiatives, including activities of another leading narcolepsy organization the Narcolepsy Network. Narcolepsy Network is a non-profit organization dedicated to providing services to educate, advocate, support and improve awareness of narcolepsy.
"Swinging for Sleep will support ongoing research and awareness activities to build a strong support system for patients, which is crucial to helping patients manage the disease," said Kevin Cosgrove, President, Wake Up Narcolepsy. "We commend Nicole Jeray for her dedication to the narcolepsy community and we are thrilled to be a part of the campaign and partnering with Jazz Pharmaceuticals."
Narcolepsy is a serious and debilitating sleep disorder that affects an estimated 125,000 to 200,000 Americans. Some people have narcolepsy for several years before being properly diagnosed. When left untreated, the symptoms can have a devastating effect on all aspects of one's life, emotionally, physically, socially and academically.
About Swinging for Sleep
Individuals are encouraged to support Swinging for Sleep in one of two ways – make a one-time donation, or pledge an amount for each birdie Jeray makes during the LPGA Symetra Tour in 2012. Nicole's success will be tracked on the Swinging for Sleep website: www.NicoleJeray.com/SwingingForSleep, and supporters should check here to follow her progress.
To learn more, visit www.WakeUpNarcolepsy.org or www.NicoleJeray.com.
Recent JAZZ News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2024 09:31:10 PM
- Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference • PR Newswire (US) • 05/01/2024 08:10:00 PM
- Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference • PR Newswire (US) • 05/01/2024 08:10:00 PM
- Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance • PR Newswire (US) • 05/01/2024 08:05:00 PM
- Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024 • PR Newswire (US) • 04/24/2024 08:05:00 PM
- Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024 • PR Newswire (US) • 04/17/2024 08:15:00 PM
- Jazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology Annual Meeting • PR Newswire (US) • 04/10/2024 11:45:00 AM
- Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer • PR Newswire (US) • 04/02/2024 11:30:00 AM
- Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024 • PR Newswire (US) • 03/12/2024 08:15:00 PM
- Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024 • PR Newswire (US) • 03/12/2024 08:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 11:07:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 02:53:55 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 02:49:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 02:48:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 02:47:06 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 11:09:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:58:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:54:55 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:52:12 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:50:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:47:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:44:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:32:32 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:28:40 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:14:03 AM
FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • BLOZF • May 7, 2024 8:51 AM